Cancer Stem Cells of Hepatocellular Carcinoma

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 May 26

PMID 29796190

Citations 14

Authors

KeWei Wang

Dianjun Sun

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma is a malignant tumor arising from hepatocytes. The hepatocellular carcinoma is dictated by a subset of cells with stem cell-like features. These cells are apoptosis-resistant and have particular biomarkers, which serve as seeds in different stages of tumorigenesis including initiation, progression, metastasis, and relapse of hepatocellular carcinoma. Signaling pathways of cancer stem cells are novel targets for the radical intervention of hepatocellular carcinoma.

Citing Articles

A Boolean model explains phenotypic plasticity changes underlying hepatic cancer stem cells emergence.

Hernandez-Magana A, Bensussen A, Martinez-Garcia J, Alvarez-Buylla E NPJ Syst Biol Appl. 2024; 10(1):99.

PMID: 39223160 PMC: 11369243. DOI: 10.1038/s41540-024-00422-9.

Superior cuproptotic efficacy of diethyldithiocarbamate-CuO nanoparticles over diethyldithiocarbamate-CuO nanoparticles in metastatic hepatocellular carcinoma.

Abu-Serie M, Barakat A, Ramadan S, Habashy N Front Pharmacol. 2024; 15:1388038.

PMID: 39076585 PMC: 11284037. DOI: 10.3389/fphar.2024.1388038.

The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma.

Yang Q, Tian H, Guo Z, Ma Z, Wang G Acta Biochim Biophys Sin (Shanghai). 2023; 55(11):1697-1706.

PMID: 37867435 PMC: 10686793. DOI: 10.3724/abbs.2023231.

Andrographolide nanophytosomes exhibit enhanced cellular delivery and pro-apoptotic activities in HepG2 liver cancer cells.

Neamatallah T, Malebari A, Alamoudi A, Nazreen S, Alam M, Bin-Melaih H Drug Deliv. 2023; 30(1):2174209.

PMID: 36762548 PMC: 9930834. DOI: 10.1080/10717544.2023.2174209.

Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.

Huang Y, Wang T, Yang J, Wu X, Fan W, Chen J Int J Nanomedicine. 2022; 17:2335-2352.

PMID: 35619893 PMC: 9128750. DOI: 10.2147/IJN.S363456.

References

Donato M, Arosio E, Monti V, Fasani P, Prati D, Sangiovanni A . Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis. Dig Liver Dis. 2002; 34(3):197-203. DOI: 10.1016/s1590-8658(02)80193-1. View

Castelli G, Pelosi E, Testa U . Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Cancers (Basel). 2017; 9(9). PMC: 5615342. DOI: 10.3390/cancers9090127. View

Guo W, Liu S, Cheng Y, Lu L, Shi J, Xu G . ICAM-1-Related Noncoding RNA in Cancer Stem Cells Maintains ICAM-1 Expression in Hepatocellular Carcinoma. Clin Cancer Res. 2015; 22(8):2041-50. DOI: 10.1158/1078-0432.CCR-14-3106. View

Williams G, Gebhardt R, Sirma H, Stenback F . Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. Carcinogenesis. 1993; 14(10):2149-56. DOI: 10.1093/carcin/14.10.2149. View

Fang C, Gong J, Zhang W . Function of oval cells in hepatocellular carcinoma in rats. World J Gastroenterol. 2004; 10(17):2482-7. PMC: 4572146. DOI: 10.3748/wjg.v10.i17.2482. View

Kawai T, Yasuchika K, Seo S, Higashi T, Ishii T, Miyauchi Y . Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using F-Fluorodeoxyglucose Positron Emission Tomography. Clin Cancer Res. 2016; 23(6):1450-1460. DOI: 10.1158/1078-0432.CCR-16-0871. View

Wu W, Zhang R, Shi X, Yi C, Xu L, Liu C . Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells. Oncol Rep. 2016; 36(1):181-8. DOI: 10.3892/or.2016.4831. View

Vance E, Soiffer R, McDonald G, Myerson D, Fingeroth J, Ritz J . Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon. Transplantation. 1996; 62(9):1358-60. DOI: 10.1097/00007890-199611150-00032. View

Takaishi S, Okumura T, Wang T . Gastric cancer stem cells. J Clin Oncol. 2008; 26(17):2876-82. PMC: 2743304. DOI: 10.1200/JCO.2007.15.2603. View

10.

Yamashita M, Wada H, Eguchi H, Ogawa H, Yamada D, Noda T . A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma. Int J Oncol. 2016; 49(1):89-98. PMC: 4902077. DOI: 10.3892/ijo.2016.3496. View

11.

Ho D, Yang Z, Yi K, Lam C, Ng M, Yu W . Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One. 2012; 7(5):e37159. PMC: 3351419. DOI: 10.1371/journal.pone.0037159. View

12.

Cheung P, Cheung T, Yip C, Ng L, Fung S, Lo C . Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget. 2016; 7(16):21644-57. PMC: 5008312. DOI: 10.18632/oncotarget.7803. View

13.

Liu Z, Dai X, Wang T, Zhang C, Zhang W, Zhang W . Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. Cancer Lett. 2017; 400:149-160. DOI: 10.1016/j.canlet.2017.04.017. View

14.

Zhang X, Jia Q, Lv L, Deng T, Gao J . Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway. Anticancer Agents Med Chem. 2015; 15(6):755-63. DOI: 10.2174/1871520615666150202111721. View

15.

Wu X, Chen D . Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol. 2006; 21(7):1093-8. DOI: 10.1111/j.1440-1746.2006.04485.x. View

16.

Lee T, Castilho A, Ma S, Ng I . Liver cancer stem cells: implications for a new therapeutic target. Liver Int. 2009; 29(7):955-65. DOI: 10.1111/j.1478-3231.2009.02040.x. View

17.

Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee E, Maynard E . Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma. Am J Surg. 2016; 212(2):238-45. DOI: 10.1016/j.amjsurg.2015.12.019. View

18.

Taniguchi H, Chiba T . Stem cells and cancer in the liver. Dis Markers. 2008; 24(4-5):223-9. PMC: 3850518. DOI: 10.1155/2008/936853. View

19.

Machida K . Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?. Hepatol Int. 2016; 11(2):143-147. PMC: 5759320. DOI: 10.1007/s12072-016-9777-7. View

20.

Li X, Luo Q, Song G . [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013; 30(4):894-8. View